Form 4 for TMO Thermo Fisher Scientific
Accepted 2022-03-02 00:00:00 ET · period of report 2022-03-01 · accession 0001127602-22-007673 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-02 | 2022-03-01 | TMO | Lagarde Michel | EVP, COO | S - Sale | $541.29 | -6,100 | 15.9K | -28% | -$3.30M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | S | D | 5,100 | $541.25 | 16,878.21 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-01 | S | D | 1,000 | $541.52 | 15,878.21 | D | — | — |